Nitto Denko Corp (6988):企業の財務・戦略的SWOT分析

◆英語タイトル:Nitto Denko Corp (6988) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0319
◆発行会社(調査会社):GlobalData
◆発行日:2019年12月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Paper and Packaging
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Nitto Denko Corp (6988) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Nitto Denko Corp (Nitto) is a manufacturer of electrical insulating materials. The company produces and distributes electronics, industrial and functional products such as polymer synthesis, and adhesive and coating technologies. The company offers value-added products such as optical films for liquid crystal displays, automotive materials and parts, membrane products, surface protective films, and double sided tapes. It provides medical products include medical surgical athletic tapes, transdermal drug delivery patches, medical surgical products, adhesive tapes, and particles for nucleic acid synthesis. It serves transportation, house equipment, infrastructure, materials, electrical, packaging and medical industries. It owns and manages manufacturing plants, sales offices, and R&D centers across the world. Nitto is headquartered in Osaka, Japan.

Nitto Denko Corp Key Recent Developments

Jun 27,2018: Nitto’s RO Membranes to Be Used for Singapore’s First Dual-mode Desalination Plant
May 14,2018: Nitto Partners with MBC BioLabs for a New San Carlos Life Science Startup Incubator

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Nitto Denko Corp – Key Facts
Nitto Denko Corp – Key Employees
Nitto Denko Corp – Major Products and Services
Nitto Denko Corp – History
Nitto Denko Corp – Company Statement
Nitto Denko Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Nitto Denko Corp – Business Description
Business Segment: Industrial Tapes
Overview
Performance
Business Segment: Life Science
Overview
Performance
Business Segment: Optronics
Overview
Performance
Business Segment: Others
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia and Oceania
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
R&D Overview
Nitto Denko Corp – Corporate Strategy
Nitto Denko Corp – SWOT Analysis
SWOT Analysis – Overview
Nitto Denko Corp – Strengths
Nitto Denko Corp – Weaknesses
Nitto Denko Corp – Opportunities
Nitto Denko Corp – Threats
Nitto Denko Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Nitto Denko Corp, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jun 27, 2018: Nitto’s RO Membranes to Be Used for Singapore’s First Dual-mode Desalination Plant
May 14, 2018: Nitto Partners with MBC BioLabs for a New San Carlos Life Science Startup Incubator
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Nitto Denko Corp, Key Facts
Nitto Denko Corp, Key Employees
Nitto Denko Corp, Major Products and Services
Nitto Denko Corp, History
Nitto Denko Corp, Other Locations
Nitto Denko Corp, Subsidiaries
Nitto Denko Corp, Key Competitors
Nitto Denko Corp, Ratios based on current share price
Nitto Denko Corp, Annual Ratios
Nitto Denko Corp, Annual Ratios (Cont...1)
Nitto Denko Corp, Annual Ratios (Cont...2)
Nitto Denko Corp, Interim Ratios
Nitto Denko Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Nitto Denko Corp, Performance Chart (2015 - 2019)
Nitto Denko Corp, Ratio Charts

★海外企業調査レポート[Nitto Denko Corp (6988):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MicroStrategy Inc (MSTR):企業の財務・戦略的SWOT分析
    MicroStrategy Inc (MSTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Equinox Energy Capital Ltd:電力:M&Aディール及び事業提携情報
    Summary Equinox Energy Capital Ltd (Equinox) is an investment management firm that invests in wind and renewable energy assets. The firm spans its expertise in permitting, construction and asset management. It acquires PV plants which have existing project finance, lease or mortgage financing. Equin …
  • Apotex Inc:企業の戦略的SWOT分析
    Apotex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • TherOx Inc:医療機器:M&Aディール及び事業提携情報
    Summary TherOx Inc (TherOx) is a medical device company that develops and commercializes SuperSaturated Oxygen (SSO2) therapies for treatment of heart attack. Its SSO2 therapy is designed to ameliorate progressive myocardial necrosis by minimizing microvascular damage in heart attack patients. TherO …
  • IOI Corp Berhad (IOICORP):企業の財務・戦略的SWOT分析
    IOI Corp Berhad (IOICORP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Croma-Pharma GmbH-医療機器分野:企業M&A・提携分析
    Summary Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company which focuses on the development and commercialization of drugs in the field of aesthetic dermatology. It offers princess injectables, princess skincare, and princess lift products. The company’s princess skincare products comprise …
  • Gabather AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Gabather AB (Gabather) is a developer of new drug candidates for the treatment of central nervous system diseases. The company spans its expertise in the development of anti-psychotics, anti-depressants and anxiolytics, analgesics, and cognition-enhancing treatments. It offers drug candidate …
  • Integrated DNA Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Integrated DNA Technologies Inc (IDT) is a biotechnology company that develops diagnostic test products. The company’s products include DNA and RNA synthesis, genotyping, modifications, nextgen sequencing, gene silencing, synthesis genes, and purifications, among others. It offers services s …
  • PPC Limited:企業の戦略・SWOT・財務情報
    PPC Limited - Strategy, SWOT and Corporate Finance Report Summary PPC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Halt Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Halt Medical Inc (Halt Medical) is a healthcare service center that develops, manufactures and commercializes medical treatment for women with symptomatic uterine fibroids. The center offers Acessa System, a minimally invasive laparoscopic outpatient procedure to treat uterine fibroids. It o …
  • Lakeland Bancorp, Inc.:企業の戦略・SWOT・財務情報
    Lakeland Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report Summary Lakeland Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Goodfellow Inc. (GDL):企業の戦略的SWOT分析
    Goodfellow Inc. (GDL) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Neuca SA (NEU):企業の財務・戦略的SWOT分析
    Neuca SA (NEU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Mr. Price Group Ltd.:企業の戦略・SWOT・財務分析
    Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • SVB Financial Group:企業の戦略・SWOT・財務情報
    SVB Financial Group - Strategy, SWOT and Corporate Finance Report Summary SVB Financial Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ImmunoGen, Inc.:企業のM&A・事業提携・投資動向
    ImmunoGen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ImmunoGen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Otto Bock HealthCare GmbH:企業の戦略的SWOT分析
    Otto Bock HealthCare GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Repros Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Repros Therapeutics Inc (Repros), formerly Zonagen Inc, a subsidiary of Allergan PLC, is a biopharmaceutical company that develops and markets drugs to treat hormonal and reproductive system disorders. The company’s pipeline product includes enclomiphene and proellex. Its enclomiphene is an …
  • GeneNews Ltd (GEN):企業の財務・戦略的SWOT分析
    Summary GeneNews Ltd (GeneNews) is a provider of molecular diagnostic products. The company develops and commercializes diagnostics and personalized medicine for cancer and other chronic diseases. Its Sentinel Principle is a novel approach to identifying biomarkers of body state using blood. GeneNew …
  • Mitsui Chemicals, Inc.:企業の戦略・SWOT・財務分析
    Mitsui Chemicals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mitsui Chemicals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆